Apimeds Pharmaceuticals US, Inc. (APUS) is a publicly traded Healthcare sector company. As of July 30, 2026, APUS trades at $5.78 with a market cap of $12.07M and a P/E ratio of -10.44. APUS moved +6.09% today. Year to date, APUS is -74.89%; over the trailing twelve months it is -67.69%. Its 52-week range spans $5.08 to $59.70. Rallies surfaces APUS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for APUS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $5.78 |
| Market Cap | $12.07M |
| P/E Ratio | -10.44 |
| EPS | $-0.55 |
| Dividend Yield | 0.00% |
| 52-Week High | $59.70 |
| 52-Week Low | $5.08 |
| Volume | 72.93K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-6.00M |
| Gross Margin | 0.00% |
APUS analyst coverage data. Average price target: $0.00.